Research Article

Pharmacodynamic Evaluation of the Gexia Zhuyu Decoction in the Treatment of NAFLD and the Molecular Mechanism Underlying the TRPM4 Pathway Regulation

Figure 4

Changes in (A) serum TC and (B) liver TC levels after the Gexia Zhuyu decoction administration. Compared with the model group (MG-NASH, 5.12 ± 0.25 nmol/L and 1.92 ± 0.14 nmol/L, n = 10), ∗∗. TC, total cholesterol.